… with esophageal inflammation, metaplasia, and neoplasia. We performed a meta-analysis
to evaluate the association of serum adipokines and insulin with Barrett’s esophagus (BE). …

… .20, 21 The insulin signaling pathway has been postulated to … of circulating adipokines (leptin,
adiponectin), insulin, as well … adipokines would be associated with the development of BE. …

… which these adipokines promote metaplasia in the esophagus needs to be explored further.
… cytokines and adipokines has been associated with esophageal cancer and other cancers. …

… of obesity-induced hyperinsulinemia and dysregulation of adipokines in these processes. …
, insulin, leptin, and adiponectin in 392 patients enrolled in the Seattle Barrett's Esophagus …

… We aimed to estimate the effect of circulating adiponectin on the risk of Barrett's esophagus
(BE), an accepted precursor of EAC, controlling for GERD symptoms and other potential …

… Leptin was the first adipokine to be discovered in 1994 [14], and hundreds of adipokines …
For example, adiponectin is an anti-inflammatory and insulin-sensitizing adipokine and is …

… between adipokine levels and risk of esophageal adenocarcinoma or Barrett esophagus. …
A stronger association between insulin levels and Barrett esophagus risk was indicated, but …

… EAC by directly affecting gastroesophageal reflux disease and Barrett’s esophagus (BE), as
… pro-inflammatory adipokines and insulin resistance. Deregulation of adipokine production, …

… In addition, there might be indirect effects of leptin through alterations in adiponectin,
growth hormone, sex hormones, or other adipokines or hormones not measured in this study. …

… Association of serum levels of adipokines and insulin with risk of Barrett's esophagus: a …
to evaluate the association of serum adipokines and insulin with Barrett’s esophagus (BE). …